Czechia vs Poland: HICP - Tea, mate and other plant-derived products for infusion (ND)
Czechia
1.49
in 2026
Poland
1.72
in 2026
Czechia rank
8th
Poland rank
5th
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Czechia
- Poland
How they compare
Poland currently reports 1.72 against 1.49 in Czechia, a difference of 0.23.
That makes Poland's figure about 1.2 times Czechia's.
The two have swapped places 2 times across 27 shared years of data; in 2000 it was Poland ahead.
Czechia ranks 8th and Poland ranks 5th of 27 countries.
Across the 3 decades both report, Czechia averaged higher in 2 and Poland in 1.
Head to head by decade
| Decade | Czechia | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.06 | 2.62 | 0.556 | Poland |
| 2010s | 1.98 | 1.98 | 0.001 | Czechia |
| 2020s | 1.83 | 1.44 | 0.3871 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Czechia or Poland?
- Poland, at 1.72 against 1.49 in Czechia as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Czechia and Poland?
- 0.23, with Poland ahead.
- How many years of comparable data are there for Czechia and Poland?
- 27 years are reported by both, from 2000 to 2026.
- How do Czechia and Poland rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Czechia ranks 8th and Poland ranks 5th of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.